Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

November 12, 2020 Leave a comment 1,347 Views

Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that will allow for the first time a true mass screening of the whole population. This test allows ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: mass screening

Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit

SiT – spatial isoform transcriptomics

Analysis of single-cell rna-seq data

AllenDigger – spatial expression data visualization, spatial heterogeneity delineation, and single-cell registration based on the Allen Brain Atlas

New research identifies an inaccuracy in the single cell GENCODE gene model

Femtosecond laser microdissection for isolation of regenerating C. elegans neurons for single-cell RNA sequencing